Innovating Works

ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS-CIC BIOGUNE

Activa
Mostrando 1 al 20 de 65 resultados
MagFetProg: Magnesium and fetal metabolic programming: an approach to preventing a life-cycle of metabolic disea... ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS-CIC BIOGUNE tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 Obesity prevalence is increasing as well as the related metabolic alterations. Obesity and T2D increase the risk of pregnancy complication a...
2024-04-23 - 2026-08-31 | Financiado
SPIRAL: Structural exploration of GD3 ganglioside-COVID spike Protein Interaction and siglec-7 Role in inhib... ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS-CIC BIOGUNE tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 The present project focuses on deeply comprehending the molecular basis of glycan recognition events by key protein receptors at atomic leve...
2024-04-10 - 2026-04-30 | Financiado
EPIMemory: Epithelial Memory to Candida albicans during commensalism and infection ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS-CIC BIOGUNE tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 In this research project I seek to discover the mechanisms underlying oral epithelial cell (OEC) memory and its importance to control Candid...
2024-03-22 - 2026-06-30 | Financiado
ADJUPROBE: LEAD ADJUVANT PROBE AS A DUAL TECHNOLOGICAL TOOL TO ADVANCE NEXT-GENERATION VACCINE DEVELOPMENT ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS-CIC BIOGUNE tramitó un HORIZON EUROPE: ERC-2023-POC The goal of ADJUPROBE is to build upon a major discovery made within the ERC-2016-STG-716878 project to validate and valorise our dual synth...
2023-11-15 - 2026-02-28 | Financiado
Glyco13Cell: Isotopically labelling of cell surface glycans to illuminate infectious processes at atomic resoluti... ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS-CIC BIOGUNE tramitó un HORIZON EUROPE: ERC-2023-STG Every human cell is covered by a dense coat of glycans (sugars, carbohydrates). Sugars are the first molecules that viruses encounter when t...
2023-11-14 - 2028-11-30 | Financiado
CARES: Human ECM based platform for anti cancer drug testing CARES CAncer dRug tESting ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS-CIC BIOGUNE tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-SE-01 With 2 million cancer-related deaths and an annual cost of €100 billion, cancer constitutes a major European challenge. Cancer treatments ha...
2023-07-03 - 2027-10-31 | Financiado
ADJU-PLATFORM: MINIMAL SAPONIN-BASED ADJUVANT VACCINE PLATFORM ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS-CIC BIOGUNE tramitó un HORIZON EUROPE: ERC-2022-POC1 ADJU-PLATFORM seeks to leverage a breakthrough made in the ERC-2016-STG-716878 project to validate a synthetic technological platform for th...
2023-03-09 - 2025-08-31 | Financiado
halt-RONIN: Discovering chronic inflammation biomarkers that define key stages in the Healthy to NASH non alcoh... Universidad Complutense de Madrid tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 Non-alcoholic fatty liver disease (NAFLD) is a multifactorial chronic inflammatory disease that is prevalent in 1 of 4 individuals with a si...
2022-11-22 - 2026-11-30 | Financiado
CoDiet: COMBATTING DIET RELATED NON COMMUNICABLE DISEASE THROUGH ENHANCED SURVEILLANCE FUNDACION AZTI - AZTI FUNDAZIOA tramitó un HORIZON EUROPE: HORIZON-CL6-2022-FARM2FORK-01 Our current understanding of the relationship between diet and the development of non-communicable disease (NCD) is limited by a number of f...
2022-10-17 - 2026-12-31 | Financiado
EVCA: Centre for Excellence in Diagnostic and Advanced Therapeutics based on Extracellular Vesicles UNIVERSIDADE NOVA DE LISBOA tramitó un HORIZON EUROPE: HORIZON-WIDERA-2021-ACCESS-03 In recent years, extracellular vesicles (EVs) have emerged within the scientific community for both biomarkers and therapeutic applications....
2022-09-09 - 2025-10-31 | Financiado
ADJUVACCINE: Development of a marketable adjuvant candidate for vaccine applications ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS-CIC BIOGUNE tramitó un HORIZON EUROPE: ERC-2022-POC2 ADJUVACCINE seeks to leverage a breakthrough made in the ERC-2016-STG-716878 project to validate a synthetic technological platform for the...
2022-07-08 - 2024-06-30 | Financiado
FIH-IO: Development of a first-in-class inhibitor of FIH for cancer immunotherapy ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS-CIC BIOGUNE tramitó un HORIZON EUROPE: ERC-2022-POC1 We plan to carry out a valorisation project for a series of novel small molecule inhibitors of Factor Inhibiting HIF (FIH) that we have deve...
2022-05-12 - 2023-11-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.